Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease

Authors

Lawrence S. Honig, Columbia University Irving Medical Center, NYS Center of Excellence for Alzheimer's Disease, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center (PH19), & Department of Neurology, Columbia University Vagelos College of Physicians & Surgeons, 630 West 168th Street (P&S UNIT 16), New York, NY, 10032-3795, USA. lh456@cumc.columbia.edu.
Marwan N. Sabbagh, Barrow Neurological Institute, Phoenix, AZ, 85013, USA.
Christopher H. van Dyck, Yale School of Medicine, New Haven, CT, USA.
Reisa A. Sperling, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Steven Hersch, Eisai Inc., Nutley, NJ, USA.
Andre Matta, Eisai Inc., Nutley, NJ, USA.
Luigi Giorgi, Eisai Co., Ltd, Hatfield, UK.
Michelle Gee, Eisai Co., Ltd, Hatfield, UK.
Michio Kanekiyo, Eisai Inc., Nutley, NJ, USA.
David Li, Eisai Inc., Nutley, NJ, USA.
Derk Purcell, Clario, Philadelphia, PA, USA.
Shobha Dhadda, Eisai Inc., Nutley, NJ, USA.
Michael Irizarry, Eisai Inc., Nutley, NJ, USA.
Lynn Kramer, Eisai Inc., Nutley, NJ, USA.

Document Type

Article

Publication Date

7-10-2024

Publication Title

Alzheimer's research & therapy

E-ISSN

1758-9193

Volume

16

Issue

1

First Page

159

PubMed ID

38987826

Digital Object Identifier (DOI)

10.1186/s13195-024-01507-7

Recommended Citation

Honig, Lawrence S.; Sabbagh, Marwan N.; van Dyck, Christopher H.; Sperling, Reisa A.; Hersch, Steven; Matta, Andre; Giorgi, Luigi; Gee, Michelle; Kanekiyo, Michio; Li, David; Purcell, Derk; Dhadda, Shobha; Irizarry, Michael; and Kramer, Lynn, "Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease" (2024). Neurology. 1888.
https://scholar.barrowneuro.org/neurology/1888